Tabuso, Cornelia G.

HRN: 04-47-19  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2025
CEFTRIAXONE 1G (VIAL)
03/18/2025
03/25/2025
IVT
2g
OD
UTI
Waiting Final Action 
03/18/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/18/2025
03/25/2025
IVT
600mg
Q8
Cellulitis
Waiting Final Action 
03/19/2025
MUPIROCIN 2%, 15G (TUBE)
03/19/2025
03/26/2025
TOPICAL
2%
BID
Cellulitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: